Circulating MicroRNA-29a: An Evolving Biomarker for Diagnosis of Pulmonary TuberculosisCorrespondence Address :
Dr. Jaya Garg,
Associate Professor, Department of Microbiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Introduction: Tuberculosis (TB) is global health problem threatening millions every year. There is urgent need of effective biomarkers for its diagnostics and circulating microRNAs (miRNAs) have recently emerged as novel and non-invasive molecular markers in blood.
Aim: To evaluate serum miRNAs as a potential biomarker for the diagnosis of pulmonary mycobacterium tuberculosis infection.
Materials and Methods: In this prospective cross-sectional study, acute pulmonary TB patients were recruited based on positive Mycobacterium tuberculosis Polymerase Chain Reaction (PCR) in sputum samples and Microarray expression profiling was performed on blood of these patients to study differentially expressed miRNAs. The results were validated by Real-Time Polymerase Chain Reaction (RT-PCR) on pulmonary TB cases and healthy controls. Studentâ€™s t-tests and Analysis of Variance (ANOVA) tests were used for statistical analysis. The p-value <0.05 was considered statistically significant.
Results: Results of microarray expression profiling showed 75 differentially expressed miRNAs in cases of pulmonary TB; among these 5 upregulated and 2 downregulated miRNAs were evaluated by RT-PCR. miRNA 29a exhibited good distinguishing efficiency; followed by miRNA 384. Receiver Operating Characteristic (ROC) curve of expression data for miRNA in cases and control groups showed that Area Under the Curve (AUC) of miRNA-29a was 0.8268 (sensitivity=80%, specificity=82%).
Conclusion: This study suggests that altered levels of serum miRNAs have great potential to serve as non-invasive biomarkers for detection of Mycobacterium tuberculosis infection. MicroRNA29a can be used as an effective biomarker for diagnosis of pulmonary TB.
Mycobacterium tuberculosis, Real-time polymerase chain reaction, TaqMan microarray
Date of Submission: Jan 08, 2021
Date of Peer Review: Feb 03, 2021
Date of Acceptance: Feb 20, 2021
Date of Publishing: Mar 01, 2021
• Financial or Other Competing Interests: As declared above
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. No
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jan 29, 2021
• Manual Googling: Feb 10, 2021
• iThenticate Software: Feb 27, 2021 (16%)
ETYMOLOGY: Author Origin
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)